Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2768483275;83276;83277 chr2:178563082;178563081;178563080chr2:179427809;179427808;179427807
N2AB2604378352;78353;78354 chr2:178563082;178563081;178563080chr2:179427809;179427808;179427807
N2A2511675571;75572;75573 chr2:178563082;178563081;178563080chr2:179427809;179427808;179427807
N2B1861956080;56081;56082 chr2:178563082;178563081;178563080chr2:179427809;179427808;179427807
Novex-11874456455;56456;56457 chr2:178563082;178563081;178563080chr2:179427809;179427808;179427807
Novex-21881156656;56657;56658 chr2:178563082;178563081;178563080chr2:179427809;179427808;179427807
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTG
  • RefSeq wild type template codon: CAC
  • Domain: Ig-141
  • Domain position: 9
  • Structural Position: 11
  • Q(SASA): 0.3837
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/G None None 0.684 N 0.489 0.278 0.766809873248 gnomAD-4.0.0 3.60097E-06 None None None None I None 0 0 None 0 0 None 0 0 3.9375E-06 0 0
V/L rs779966248 -0.272 0.003 N 0.091 0.052 0.558342666981 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 5.57E-05 None 0 None 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.25 likely_benign 0.2423 benign -0.87 Destabilizing 0.309 N 0.315 neutral N 0.457097561 None None I
V/C 0.8293 likely_pathogenic 0.8066 pathogenic -0.791 Destabilizing 0.02 N 0.266 neutral None None None None I
V/D 0.786 likely_pathogenic 0.7837 pathogenic -0.264 Destabilizing 0.91 D 0.494 neutral None None None None I
V/E 0.7154 likely_pathogenic 0.6882 pathogenic -0.336 Destabilizing 0.884 D 0.481 neutral N 0.486380318 None None I
V/F 0.3513 ambiguous 0.3617 ambiguous -0.81 Destabilizing 0.91 D 0.452 neutral None None None None I
V/G 0.3294 likely_benign 0.3318 benign -1.077 Destabilizing 0.684 D 0.489 neutral N 0.439378592 None None I
V/H 0.854 likely_pathogenic 0.8391 pathogenic -0.593 Destabilizing 0.996 D 0.441 neutral None None None None I
V/I 0.0885 likely_benign 0.0858 benign -0.449 Destabilizing 0.037 N 0.183 neutral None None None None I
V/K 0.8437 likely_pathogenic 0.8198 pathogenic -0.708 Destabilizing 0.742 D 0.49 neutral None None None None I
V/L 0.3165 likely_benign 0.3003 benign -0.449 Destabilizing 0.003 N 0.091 neutral N 0.508507816 None None I
V/M 0.1864 likely_benign 0.1811 benign -0.452 Destabilizing 0.078 N 0.19 neutral N 0.508854533 None None I
V/N 0.427 ambiguous 0.4318 ambiguous -0.452 Destabilizing 0.91 D 0.476 neutral None None None None I
V/P 0.777 likely_pathogenic 0.7706 pathogenic -0.553 Destabilizing 0.953 D 0.464 neutral None None None None I
V/Q 0.6724 likely_pathogenic 0.6438 pathogenic -0.653 Destabilizing 0.953 D 0.457 neutral None None None None I
V/R 0.8233 likely_pathogenic 0.8008 pathogenic -0.222 Destabilizing 0.953 D 0.477 neutral None None None None I
V/S 0.3413 ambiguous 0.3337 benign -0.936 Destabilizing 0.59 D 0.413 neutral None None None None I
V/T 0.1671 likely_benign 0.1793 benign -0.899 Destabilizing 0.037 N 0.229 neutral None None None None I
V/W 0.9347 likely_pathogenic 0.9288 pathogenic -0.89 Destabilizing 0.996 D 0.463 neutral None None None None I
V/Y 0.7577 likely_pathogenic 0.7356 pathogenic -0.608 Destabilizing 0.953 D 0.419 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.